Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease

Clinical Therapeutics

Volumn 32, Issue 9, 2010, Pages 1610-1617

  Koyasu, Masayoshi ^a,b   Ishii, Hideki ^a   Watarai, Masato ^b   Takemoto, Kenji ^b   Inden, Yasuya ^a   Takeshita, Kyosuke ^a   Amano, Tetsuya ^a   Yoshikawa, Daiji ^a   Matsubara, Tatsuaki ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ANJO KOSEI HOSPITAL   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Acarbose; Carotid intima media thickness; Impaired glucose tolerance; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; CHOLESTEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIARRHEA; DISEASE SEVERITY; DRUG EFFECT; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; STROKE;

ACARBOSE; AGED; BLOOD GLUCOSE; CAROTID ARTERY, COMMON; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; JAPAN; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUNICA INTIMA;

EID: 77958165599     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.07.015     Document Type: Article

References (25)

1. Brun E, Nelson RG, Bennett PH, et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000, 23:1119-1123. Verona Diabetes Study.
2. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 Years of follow-up. Arch Intern Med. 2001, 161:1717-1723.
3. Fox CS, Sullivan L, D'Agostino RB, Wilson PW The significant effect of diabetes duration on coronary heart disease mortality: The Framingham Heart Study. Diabetes Care 2004, 27:704-708. Framingham Heart Study Group.
4. Burchfiel CM, Reed DM, Marcus EB, et al. Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. An autopsy study from the Honolulu Heart Program. Am J Epidemiol. 1993, 137:1328-1340.
5. Cho E, Rimm EB, Stampfer MJ, et al. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002, 40:954-960.
6. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998, 316:823-828.
7. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999, 22:920-924.
8. Bonora E, Muggeo M Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: The epidemiological evidence. Diabetologia 2001, 44:2107-2114.
9. Hulin B New hypoglycaemic agents. Prog Med Chem. 1994, 31:1-58.
10. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002, 359:2072-2077. STOP-NIDDM Trial Research Group.
11. Hanefeld M, Chiasson JL, Koehler C, et al. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004, 35:1073-1078.
12. Yamasaki Y, Katakami N, Hayaishi-Okano R, et al. Alpha-glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Clin Pract. 2005, 67:204-210.
13. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999, 340:14-22. Cardiovascular Health Study Collaborative Research Group.
14. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000, 151:478-487.
15. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intimamedia thickness in predicting clinical coronary events. Ann Intern Med. 1998, 128:262-269.
16. Treatment Guide for Diabetes 2007 (in English) 2007, Japan Diabetes Society, Tokyojapan.
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Armitage P, Berry G, Matthews JN Statistical Methods in Medical Research 2002, Blackwell Scientific Publications, Oxford, UK. 4th ed.
19. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339:229-234.
20. Bischoff H The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clin Invest Med. 1995, 18:303-311.
21. Ceriello A, Taboga C, Tonutti L, et al. Post-meal coagulation activation in diabetes mellitus: The effect of acarbose. Diabetologia 1996, 39:469-473.
22. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999, 34:146-154.
23. Hanefeld M, Cagatay M, Petrowitsch T, et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies. Eur Heart J. 2004, 25:10-16.
24. Mazzone T, Meyer PM, Feinstein SB, et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: A randomized trial. JAMA 2006, 296:2572-2581.
25. Matsumoto K, Sera Y, Abe Y, et al. Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes Res Clin Pract. 2004, 64:225-228.